Simcere Pharmaceutical Group

	Home

	Corporate Governance

	AGM Summary

	SEC Filings

	Financial Reports

	Stock Information

	Press Releases

	Event Calendar

	Analyst Coverage

	E-mail Alerts

	Investor Kit

	Information Request

	Contact IR

SEC Filings

Print Page |

E-mail Page |

RSS Feeds |

E-mail Alerts |

IR Contacts |

Financial Tear Sheet

Receive E-mail Alerts

We will provide a hard copy of our complete audited financial statements, free of charge, to our shareholders and ADS holders upon request.

Please send your request to:
Simcere Pharmaceutical Group
No.699-18, Xuanwu Avenue, Xuanwu District,
Nanjing, P.R. China, 210042
Tel: +86 25 8556 6666x8857
Fax:+86 25 8547 1729
E-mail: IR@simcere.com

SEC Filing Keyword Search (View search tips)

Groupings Filter (View SEC Groupings descriptions)

View Section 16 Filings (3,4,5)

<< First | Previous | Next | Last >>

Filing Date	Form	Description	Filing Group	Downloads
05/10/13	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports
04/26/13	20-F	Registration of securities of foreign private issuers pursuant to section 12(b) or (g)	Annual Filings
04/10/13	SC 13D/A	An amendment to a SC 13D filing	Other
04/03/13	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports
04/01/13	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Other
03/25/13	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports
03/21/13	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Other
03/12/13	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Other
03/12/13	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports
03/11/13	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports

<< First | Previous | Next | Last >>

Design by 71nc.com